Literature DB >> 8611396

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.

G Damia1, L Imperatori, L Citti, L Mariani, M D'Incalci.   

Abstract

The activities and the expression of 3-methyladenine glycosylase (3-meAde gly) and O6-alkylguanine-DNA-alkyltransferase (O6 ATase) were investigated in ten human cancer cell lines. Both 3-meAde gly and O6 ATase activities were variable among different cell lines. mRNA levels of the O6 ATase gene, appeared to be related to the content of O6 ATase in different cell lines, whereas no apparent correlation was found between mRNA of 3-meAde gly and the enzyme activity. No correlation was found between the activity of the two enzymes and the sensitivity to alkylating agents of different structures such as CC-1065, tallimustine, dimethylsulphate (DMSO), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), cis-diamminedichloroplatinum (cDDP) and melphalan (L-PAM). The most striking finding of this study is that a correlation exists between the activity of O6 ATase and 3-meAde gly in the various cell lines investigated (P<0.01), suggesting a common mechanism of regulation of two DNA repair enzymes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611396      PMCID: PMC2074260          DOI: 10.1038/bjc.1996.153

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  46 in total

1.  Two enzymes are required from strand incision in repair of alkylated DNA.

Authors:  J Laval
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

2.  Possible relevance of O-6 alkylation of deoxyguanosine to the mutagenicity and carcinogenicity of nitrosamines and nitrosamides.

Authors:  A Loveless
Journal:  Nature       Date:  1969-07-12       Impact factor: 49.962

3.  DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.

Authors:  M Broggini; H M Coley; N Mongelli; E Pesenti; M D Wyatt; J A Hartley; M D'Incalci
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

4.  Induction of a DNA glycosylase for N-methylated purines is part of the adaptive response to alkylating agents.

Authors:  P Karran; T Hjelmgren; T Lindahl
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

5.  Adaptation to alkylation resistance involves the induction of a DNA glycosylase.

Authors:  G Evensen; E Seeberg
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

6.  Repair of alkylated DNA in Escherichia coli. Methyl group transfer from O6-methylguanine to a protein cysteine residue.

Authors:  M Olsson; T Lindahl
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

Review 7.  DNA damage tolerance, mismatch repair and genome instability.

Authors:  P Karran; M Bignami
Journal:  Bioessays       Date:  1994-11       Impact factor: 4.345

8.  Repair of O6-ethylguanine in DNA by a chromatin fraction from rat liver: transfer of the ethyl group to an acceptor protein.

Authors:  J R Mehta; D B Ludlum; A Renard; W G Verly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Evidence for the simultaneous expression of alternatively spliced alkylpurine N-glycosylase transcripts in human tissues and cells.

Authors:  A Pendlebury; I M Frayling; M F Santibanez Koref; G P Margison; J A Rafferty
Journal:  Carcinogenesis       Date:  1994-12       Impact factor: 4.944

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  3 in total

1.  Mechanisms of resistance to alkylating agents.

Authors:  G Damia; M D'Incalci
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX.

Authors:  Carole Vitellius; Caroline Eymerit-Morin; Dominique Luet; Lionel Fizanne; Fanny Foubert; Sandrine Bertrais; Marie-Christine Rousselet; François-Xavier Caroli-Bosc
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

3.  Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents.

Authors:  G Colella; S Marchini; M D'Incalci; R Brown; M Broggini
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.